Pharma & Biotech

When a medical technology company delivers explosive earnings that shatter expectations yet sees its shares lose momentum, investors face a...

Trevi Therapeutics shares are demonstrating remarkable momentum with a sustained upward trajectory that has captured market attention. In the latest...

The shares of Actinium Pharmaceuticals are experiencing a pronounced downward trajectory, marking their fourth consecutive losing session as clear bearish...

Skye Bioscience faces a defining period with two critical events scheduled this week. The biotechnology firm is set to present...

Cellectar Biosciences saw its shares advance significantly during Thursday's trading session following the company's announcement of its quarterly earnings date....

Lantheus, a prominent player in the radiopharmaceutical sector, finds itself at a pivotal juncture. The company's latest quarterly report reveals...

Sensei Biotherapeutics finds itself in a precarious position as the company confronts a fundamental threat to its continued operations. The...

Iovance Biotherapeutics witnessed a dramatic upswing in its share price, climbing more than 20 percent in a single trading session....

Intellia Therapeutics faced a severe market downturn following the disclosure of a patient death in a pivotal Phase 3 clinical...

Ocugen's latest quarterly earnings report has triggered alarm bells across the investment community. The clinical-stage biopharmaceutical company reported a significantly...